Industry Stakeholders Support Revision of Switzerland’s Therapeutic Products Act
I. Overview of proposed key changes The Swiss Federal Act on Medicinal Products and Medical Devices (Swiss Therapeutic Products Act, TPA), which has been in force since 2002, is currently undergoing its third revision. The proposed changes are designed to improve the safety and quality of medicinal products and medical devices (therapeutic products). The […]
The post Switzerland’s Therapeutic Products Act Revision: Industry Stakeholders Show Positive Support appeared first on Healthcare & Life Sciences Blog.
Read More